Polypropylene mesh used as a mid-urethral sling is associated with severe clinical complications in a significant minority of patients. Current in vitro mechanical testing shows that polypropylene responds inadequately to mechanical distension and is also poor at supporting cell proliferation.
Aims and Objectives
Our objective therefore is to produce materials with more appropriate mechanical properties for use as a sling material but which can also support cell integration.
Scaffolds of two polyurethanes (PU), poly-L-lactic acid (PLA) and co-polymers of the two were produced by electrospinning. Mechanical properties of materials were assessed and compared to polypropylene. The interaction of adipose derived stem cells (ADSC) with the scaffolds was also assessed. Uniaxial tensiometry of scaffolds was performed before and after seven days of cyclical distension. Cell penetration (using DAPI and a fluorescent red cell tracker dye), viability (AlamarBlue assay) and total collagen production (Sirius red assay) were measured for ADSC cultured on scaffolds.
Polypropylene was stronger than polyurethanes and PLA. However, polypropylene mesh deformed plastically after 7 days of sustained cyclical distention, while polyurethanes maintained their elasticity. Scaffolds of PU containing PLA were weaker and stiffer than PU or polypropylene but were significantly better than PU scaffolds alone at supporting ADSC.
Citation: Hillary CJ, Roman S, Bullock AJ, Green NH, Chapple CR, MacNeil S (2016) Developing Repair Materials for Stress Urinary Incontinence to Withstand Dynamic Distension. PLoS ONE 11(3): e0149971. doi:10.1371/journal.pone.0149971
Editor: Shay Soker, Wake Forest Institute for Regenerative Medicine, UNITED STATES
Received: August 10, 2015; Accepted: February 8, 2016; Published: March 16, 2016
Copyright: © 2016 Hillary et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This work was supported by a grant from the TRUST European Marie Curie Network, The Urology Foundation Scholarship 2015 (CH) and the Robert Luff Foundation (CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
In the UK, there is a 3.6% lifetime risk for a female patient to undergo surgery for stress urinary incontinence . The most common surgical repair technique involves the use of non-degradable polypropylene (PPL) mesh to support the urethra and counteract sphincter weakness in the treatment of SUI . These repurposed hernia repair meshes became popular due to their success, their ease of use, and the limitations of biological alternatives [3, 4]. Allografts and xenografts have high recurrence rates and tissue encapsulation respectively [5, 6]. Autologous fascia is arguably the most appropriate material for surgical repair but requires longer operating times, can result in donor site morbidity and some patients have insufficient tissue for this to be a viable option.
Use of mesh for the treatment of SUI was popularized by Petros et al  in 1990, based on the integral theory and the recognition that sphincteric weakness leads to a severe subgroup of SUI, which is not adequately treated with conventional open surgery  and was commercialized in 1995. However, in 2013, after nearly two decades of PPL mesh use for the treatment of SUI, the US Food and Drug Administration (FDA) began publishing notifications on the safety of PPL mesh devices due to the increasing awareness of mesh complications. Manufacturers have subsequently withdrawn several mesh implants for the treatment of pelvic organ prolapse (POP), while there is increasing concern over the use of this mesh for the treatment of SUI as complications can take several years to present
Mesh exposure has been reported in over 4% of patients undergoing a trans-vaginal tape (TVT) procedure for SUI [9, 10]. Although the exact mechanism involved in the development of mesh related complications is not completely understood, current literature supports the view that PPL mesh exposure is due to poor tissue integration, host immune attack and excessive fibrosis of the implant . It has been proposed that the biomechanical mismatch between the strong, rigid PPL mesh and the elastic paravaginal tissue, under constant dynamic distension, can lead to PPL becoming plastically deformed . This is supported by in vivo data that demonstrates that PPL mesh implanted in a sheep vagina extrudes within 2–3 months but not when implanted abdominally , illustrating the site-specific responses to PPL. In the female pelvic floor, any repair material must survive years of dynamic distension. A study using a newly developed device for measuring intra-vaginal pressure in women has elucidated the acute forces that occur during sudden increases in abdominal pressures, such as sneezing, coughing, and laughing , which may have been previously under appreciated.
Tissue engineering approaches to develop materials for pelvic floor repair that can lead to long-term success have recently begun to be explored [15–17]. The “ideal” repair material should remain relatively elastic to cope with the forces experienced with routine events such as coughing or sneezing, but become reversibly stronger at higher strain, similar to native healthy fascia . Furthermore, materials should be biocompatible and reflect the properties of the tissues into which it is implanted . Biodegradable materials ideally undergo controlled degradation over a period that permits tissue remodeling (an M2 macrophage response) with fibroblast ingrowth, ECM production, and angiogenesis . Non-degradable materials that result in an acute inflammatory response, persisting to a chronic phase (M1 macrophage response) may be associated with infection and erosion , while materials that fail to initiate an M2 response can become encapsulated .
Our aim is to design an electrospun sling for SUI, which mimics autologous tissue. As a key step towards this we here explore polyurethanes, which demonstrate greater elasticity and biocompatibility than polypropylene when used in abdominal hernia repair . We also investigate a combination of polyurethanes and electrospun poly-L-lactic acid scaffolds as the latter show good cell attachment and matrix production in vitro , and these became well integrated on implantation into rats over 7 days .
Materials and Methods
Poly-L-lactic acid ((PLA) Goodfellow, Cambridge, UK)) at 10% (wt/v) was dissolved in dichloromethane (DCM). Polyurethanes (PU) Z1 and Z3 (Biomer technologies, Cheshire, UK) were dissolved in 50:50 dimethylformide:tetrahydrofuran (DMF:THF) at 6% (wt/v) and 70:30 DMF:THF at 10% (wt/v) respectively. PPL mesh (GynecareTM, Johnson & Johnson) was used as supplied.
Polymer solutions (20mls total) were loaded into 5ml syringes fitted with blunt tipped 21G needles, placed into a syringe pump (GenieTMPlus, Kent Scientific, USA), and delivered at 40μl/min per syringe. Microfibres were created with an accelerating voltage of 17kV DC from a high voltage supply (Genvolt, UK) and collected on an aluminium foil covered earthed mandrel (80mm diameter, 160mm length) rotating at 300rpm, with a needle to collector distance of 17cm at 21°C and ~30% humidity.
Co-polymer scaffolds of Z1:PLA were formed by simultaneously delivering two individual polymer solutions to the collector from polymer delivery equipment placed either side of the mandrel as depicted in Fig 1. These co-polymers consisted of either 4 syringes of Z1 to 1 syringe of PLA (4:1 Z1 to PLA termed Z1 high (20%) PLA) or 10 syringes of Z1 to 1 syringe of PLA (10:1—Z1 low (9%) PLA). Scaffolds were dried at room temperature for 24 hours prior to storage at -20°C.
Testing Biomechanical Properties of Scaffolds under Static Conditions and following Dynamic Loading
Samples of all materials were placed in a tensiometer (BOSE Electroforce instruments, Minnesota, USA). Mechanical properties were measured using a ramp test, elongating the material at a rate of 0.1 mm/s or a cyclic test with a rate of 1mm/s up to 25% of displacement from its original length at 50 cycles. Results are standardized by width and thickness of materials (N/mm2)
For dynamic loading, samples measuring 3cm x 1cm were placed in a TC-3 load bioreactor (EBERS Medical Technology SL, Zaragoza, Spain) and subjected to cyclic uniaxial distension using 25% elongation, 0.1mm/s rate and 18 cycles per minute over 7 days in Dulbecco’s modified Eagle’s medium (DMEM) at 37°C, 5% CO2. Samples were then assessed for mechanical properties as above.
Data was plotted as stress vs strain and the initial linear gradient of each curve was taken as the Young’s modulus (N/mm2). Both values were compared to values published for paravaginal tissues of healthy premenopausal patients .
Adipose-Derived Mesenchymal Stem Cell (ADSC) Culture
ADSC were isolated from human subcutaneous fat, donated by patients giving informed consent under a research tissue bank license (number 08/H1308/39) under the Human Tissue Authority. Isolation and culture were performed as previously described from 10 mL of fat tissue .
Cells were cultured in DMEM supplemented with 10% (v/v) fetal calf serum (FCS) (Advanced Protein Products, Brierley Hill, UK), 2mM glutamine, 0.625μg/mL amphotericin B, 100IU/mL penicillin and 100μg/mL streptomycin (Gibco Invitrogen, Paisley, UK).
Sample Preparation and Culture of Cells on Scaffolds
Scaffolds were cut to 1.5 x 1.5cm and sterilized in 70% ethanol for 20 minutes followed by 3 washes in PBS.
500,000 passage 6 ADSC were seeded per scaffold into the centre of steel rings (internal diameter 1cm) placed onto each scaffold, creating a defined area for cell attachment. Rings were removed after 12 hours and samples cultured for 2 weeks at 37°C, 5% CO2. DMEM was changed three times per week.
Assessment of Cell Metabolic Activity on Scaffolds via AlamarBlue™ Assay
The metabolic activity of cells cultured on scaffolds was quantified by AlamarBlue™ (Resazurin; Sigma-Aldrich, Dorset, UK) assay at days 7 and 14. Media was removed and scaffolds were washed three times with PBS. 1mL per well of sterile Resazurin (5mg/ml) was added and cells incubated for one hour. 50μl of each sample was aspirated and the optical density measured at 570nm using a colorimetric plate reader.
Assessment of Collagen Production on Scaffolds Using Sirius Red Staining
Total collagen production was measured for each scaffold. Following three washes with PBS, 1ml of 0.1% solution of Sirius Red F3B in saturated picric acid was added and samples incubated for 18 hours at room temperature. Samples were washed with PBS until no further stain was eluted. Samples were then weighed and photographed. Stain was eluted using 1ml per well of 0.2M NaOH:MeOH (1:1), and the optical density measured at 490nm using a colorimetric plate reader.
Examination of Cell Penetration into Scaffolds
Several methods were used to image cell penetration into scaffolds.
DAPI staining of cell nuclei was done post culture of cells on scaffolds. Samples were fixed for 20 minutes in 3.7% formaldehyde and incubated for 40 min in 0.8 ml of 1 ng/ml DAPI (Gibco Invitrogen, Paisley, UK). After three washes in PBS, constructs were imaged with an Axon ImageXpressTM fluorescence microscope (Molecular Devices limited, Union City, CA) at an excitation and emission wavelengths of λex385 nm/λem461 nm.
Scanning electron microscopy of cells on scaffolds for these same fixed samples was also undertaken. Samples were processed as previously described  and gold sputter coated (Edwards sputter coater S150B, Crawley, England). Samples were imaged using a Phillips XL-20 scanning electron microscope (Cambridge, UK).
For imaging of live cells within scaffolds, a fluorescent dye was used to label the cells and second harmonic generation was used to image the scaffolds.
500,000 ADSC were seeded on each of the 5 sterilised scaffolds as previously described and incubated with media (DMEM) changed three times per week. Cell-scaffolds were cultured for 3 weeks, following which, 0.5mls of serum free DMEM with 10μM celltracker™ red CMTPX (Invitrogen, Oregon USA) was added per well and incubated for one hour. Cells were imaged live, using a Zeiss LSM 510 Meta upright laser-scanning confocal microscope (Carl Zeiss MicroImaging, Germany) using a 40x 1.3 NA oil immersion objective attached to a tuneable (700–1060 nm) Chameleon Ti:sapphire multiphoton laser (Coherent, CA, USA) for second harmonic generation (SHG) signal. Red cell tracker signal was created by illuminating constructs at 543nm with 30% transmission and detected between 565nm and 615nm.
For SHG signal, constructs were illuminated at 840nm and signals were detected between 415nm and 426nm. Images (512 x 512), with a pixel dwell time of 6.39 μs were captured at a range of depths by moving the focal plane down from the surface of the scaffold, where there was the greatest number of cells present and without any polymer fibres visible, at 1μm intervals until no further cells were visible and polymer fibres dominated the field of view.
Electrospinning of Scaffolds
Scaffolds were either electrospun individually (PLA, Z1 or Z3) or co-electrospun to produce interwoven fibres of Z1 and PLA. All electrospun materials had a microfibrous, microporous structure. PLA had a mean fibre diameter of 2.5μm (shown previously ) compared to polyurethane fibres of 1μm. Pore size was 40μm and 20μm respectively. Co-polymers of PLA and Z1 resembled PLA, particularly at the higher PLA content (Fig 2).
Cell Culture on Scaffolds
Fig 2 shows SEM of ADSC cultured on scaffolds for 2 weeks, demonstrating dense surface matrix coverage. DAPI staining shows cells growing throughout the scaffolds and producing collagen as depicted by staining with Sirius red.
A quantitative assessment of these results is shown in Fig 3 and S1 Table. All scaffolds (n = 9) supported an increase in cell viability from day 7 to day 14, however the greatest increase was seen in those scaffolds containing PLA.
Cells cultured on scaffolds of either PLA or PLA/Z1 showed a significant four-fold increase in total collagen expression compared to that seen on Z1 or Z3 alone after 14 days of culture (n = 9) (Fig 4 and S2 Table).
Assessment of Mechanical Properties of Scaffolds
Fig 5A shows stress-strain curves for the 1st, 2nd, and 5th cycles of uniaxial tensiometry of dry scaffolds. Percentage deformation (shown in Fig 5B) was calculated as the percentage of change in strain prior to stress at cycle 2. This shows that Z1 was completely elastic, as was Z3, and Z1 with low (9%) PLA co-polymer. By contrast PLA and Z1 with high (20%) PLA underwent significant deformation. PPL showed plastic deformation but to a lesser degree than either PLA or high PLA co-polymers. In addition, all scaffolds containing PLA showed a significant reduction in the Young’s modulus from the 1st to the 2nd cycle (Fig 5C).
(a) Strain-stress plots of the 1st, 2nd and 5th cycle. (b) Plastic deformation (%) at the 2nd cycle. (c) Young’s modulus of the 1st and 2nd cycle (n-3±SEM), *p<0.05, **p<0.01.
PPL, PLA, Z1, and Z3 were subsequently assessed before and after 7 days of dynamic distension and stress strain curves are shown in Fig 6. After only 7 days of dynamic distention, PLA became brittle and failed, while PPL increased in stiffness before failing (as indicated by arrows). In contrast Z3 and Z1 both remained elastic.
Ramp uniaxial tensile test before (A) and after (B) 7 days under dynamic distention in an EBERS bioreactor.
Fig 7, S3 Table and S4 Table shows the Young’s modulus and ultimate tensile strength (UTS) for each scaffold in comparison with healthy paravaginal tissues (indicated by the dotted lines) . Only Z1 did not show any changes in Young’s modulus and UTS after 7 days under dynamic loading. Z3 became stiffer and stronger, PLA became stiffer and weaker while PPL became stiffer, its strength unchanged.
Young’s Modulus (top) and ultimate tensile strength (bottom) calculated from stress curves before and after 7 days of uniaxial distension (n-2±SEM), *p<0.05, **p<0.01, ***p<0.001. Dotted lines represent values of healthy paravaginal tissues .
Investigation of Cell Penetration into Scaffolds Using Fluorescence Microscopy and Second Harmonic Generation
Unfixed constructs were imaged after 3 weeks of culture at 1μm intervals from the surface (point 0). Red cell-tracker signals were combined with SHG signals for each interval and the results at 4 μm intervals are presented in Fig 8. This demonstrates that cells were present within the PLA fibre pores and were able to penetrate this scaffold to the greatest degree of all constructs tested, followed by the polyurethane Z3 scaffold. Meanwhile, a dense collection of cells was located solely on the surface of polyurethane Z1 scaffolds, without any evidence of cells within polymer fibres. For Z1 high PLA and Z1 low PLA scaffolds, cells were able to integrate within the pores to a lesser degree than PLA scaffolds.
Cells (red) and fibre SHG signal (green) for each of the 5 constructs imaged from the scaffold surface (0μm) to 20μm depth. All scale bars equivalent to 50μm.
Table 1 summarises the mechanical properties of the scaffolds, including their response to repeated dynamic strain and their ability to support cell proliferation and matrix production.
Our aim was to design a biocompatible repair material sling for the treatment of stress urinary incontinence, in light of the complications associated with polypropylene mesh. We investigated the use of electrospun polyurethane scaffolds to replicate the mechanical properties of healthy fascia and also assessed cell attachment and matrix production, as in vivo post implantation this is expected to occur. Any materials for load-bearing must have adequate mechanical properties to fulfill a supportive role of the weakened tissue in addition to being biocompatible.
The key finding of this study is that subjecting materials in vitro to dynamic strain reveals significant changes in their mechanical properties after only 7 days. PPL and PLA both failed mechanically, while polyurethanes Z1 and Z3 coped well with dynamic strain. However, PLA is superior at supporting cellular interactions and new matrix production. We suggest that this dynamic assessment is crucial in the development of materials for use in the pelvic floor.
Human ADSC were used as a cell source for this study for investigating the interaction of materials with cells, as these cells are more proliferative and better defined than fibroblasts  and in vivo may well be recruited to implanted biomaterials.
The implantation of a weak material could lead to recurrence of SUI, while a strong but inelastic material, such as PPL will provide mechanical support but is ultimately incompatible with the pelvic floor environment, which could lead to fibrosis and chronic inflammation.
Table 1 summarises the key properties of the investigated materials, showing polyurethane Z3, which is slowly degradable (over 5–10 years) has mechanical characteristics similar to native fascia. By interweaving fibres of Z1 with PLA, we significantly improved the interaction of the scaffolds with cells, despite a reduction in material strength and the ability of cells to penetrate the scaffolds.
In developing materials for the pelvic floor, it was not appreciated until recently that there are site-specific differences seen with “soft” tissues. Evidence from studies using sheep models show that while PPL performs well in the abdominal wall, it extrudes through pelvic floor tissues within months of implantation into the vagina . It has also been demonstrated recently that although polypropylene mesh is strong, it is unsuited to dynamic distension with irreversible deformation during cyclical loading .
There is no simple correlation between the strength of implants and clinical success . Some non-degradable biomaterials lead to sustained inflammation  and are associated with complications years after their use for POP or SUI. Thus, biomaterials for use in the pelvic floor need to be both mechanically suitable and not provoke sustained inflammation.
Accordingly we evaluated polyurethanes as potential graft materials. These are popular in vascular and bone tissue engineering due to their elasticity and biocompatibility. Bergmeister et al  demonstrated endothelial cell proliferation and 100% graft patency in cylindrical PU grafts one-year post implantation. Takanari et al  showed greater elasticity and anti-inflammatory properties, of polyurethanes compared to PPL and other potential repair materials for hernia repair Hence we investigated the mechanical properties of electrospun scaffolds of polyurethanes, of PLA and PPL and of combinations of PU and PLA and compared these values to those reported in the literature for native healthy fascia. We also assessed cell interactions with these materials and demonstrated that cells are able to penetrate PLA scaffolds and to a lesser degree, polyurethane Z3.
In conclusion, the surgical repair of SUI and particularly the implantation of synthetic materials into the pelvic floor environment raises particular challenges that need to be considered in order to design appropriate new materials, which will provide a sustained and successful repair without the complication observed with PPL. We demonstrate that it is possible to develop a composite PU/PLA material, which out-performs PPL both in response to dynamic distension and in its ability to interact well with cells in vitro. We suggest a combination of these FDA approved materials could be more suitable than PPL for successful implantation and long-term survival for the management of both SUI and POP based on this in vitro work.
S1 Table. Raw data for cell metabolic activity testing.
S2 Table. Raw data for total collagen production.
S3 Table. Raw data for tensile and cyclical uniaxial mechanical testing.
S4 Table. Raw data for dynamically distended materials.
This work was supported by a grant from the TRUST European Marie Curie Network, The Urology Foundation and the Robert Luff Foundation.
Conceived and designed the experiments: CH SR SM CC. Performed the experiments: CH SR AB NG. Analyzed the data: CH SR NG. Contributed reagents/materials/analysis tools: CH SR AB NG. Wrote the paper: CH SR AB SM CC.
- 1. Abdel-Fattah M, Familusi A, Fielding S, Ford J, Bhattacharya S. Primary and repeat surgical treatment for female pelvic organ prolapse and incontinence in parous women in the UK: a register linkage study. BMJ open. 2011;1(2):e000206. Epub 2011/11/22. doi: 10.1136/bmjopen-2011-000206 pmid:22102637; PubMed Central PMCID: PMC3221293.
- 2. Petros PE, Ulmsten UI. The combined intravaginal sling and tuck operation. An ambulatory procedure for cure of stress and urge incontinence. Acta obstetricia et gynecologica Scandinavica Supplement. 1990;153:53–9. Epub 1990/01/01. pmid:2093274.
- 3. Abed H, Rahn DD, Lowenstein L, Balk EM, Clemons JL, Rogers RG, et al. Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. International urogynecology journal. 2011;22(7):789–98. Epub 2011/03/23. doi: 10.1007/s00192-011-1384-5 pmid:21424785.
- 4. Guerrero KL, Emery SJ, Wareham K, Ismail S, Watkins A, Lucas MG. A randomised controlled trial comparing TVT, Pelvicol and autologous fascial slings for the treatment of stress urinary incontinence in women. BJOG: an international journal of obstetrics and gynaecology. 2010;117(12):1493–502. Epub 2010/10/14. doi: 10.1111/j.1471-0528.2010.02696.x pmid:20939862.
- 5. McBride AW, Ellerkmann RM, Bent AE, Melick CF. Comparison of long-term outcomes of autologous fascia lata slings with Suspend Tutoplast fascia lata allograft slings for stress incontinence. American journal of obstetrics and gynecology. 2005;192(5):1677–81. doi: 10.1016/j.ajog.2005.01.078 pmid:15902176.
- 6. Woodruff AJ, Cole EE, Dmochowski RR, Scarpero HM, Beckman EN, Winters JC. Histologic comparison of pubovaginal sling graft materials: a comparative study. Urology. 2008;72(1):85–9. doi: 10.1016/j.urology.2008.03.012 pmid:18455763.
- 7. Petros PE, Ulmsten UI. An integral theory of female urinary incontinence. Experimental and clinical considerations. Acta obstetricia et gynecologica Scandinavica Supplement. 1990;153:7–31. pmid:2093278.
- 8. McGuire EJ. Urodynamic findings in patients after failure of stress incontinence operations. Progress in clinical and biological research. 1981;78:351–60. pmid:7335750.
- 9. Jones R, Abrams P, Hilton P, Ward K, Drake M. Risk of tape-related complications after TVT is at least 4%. Neurourology and urodynamics. 2010;29(1):40–1. Epub 2009/12/22. doi: 10.1002/nau.20851 pmid:20025030.
- 10. Brubaker L, Norton PA, Albo ME, Chai TC, Dandreo KJ, Lloyd KL, et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. American journal of obstetrics and gynecology. 2011;205(5):498 e1-6. doi: 10.1016/j.ajog.2011.07.011 pmid:21925636; PubMed Central PMCID: PMC3205289.
- 11. Gigliobianco G, Regueros SR, Osman NI, Bissoli J, Bullock AJ, Chapple CR, et al. Biomaterials for pelvic floor reconstructive surgery: how can we do better? BioMed research international. 2015;2015:968087. doi: 10.1155/2015/968087 pmid:25977927; PubMed Central PMCID: PMC4419215.
- 12. Li X, Kruger JA, Jor JW, Wong V, Dietz HP, Nash MP, et al. Characterizing the ex vivo mechanical properties of synthetic polypropylene surgical mesh. Journal of the mechanical behavior of biomedical materials. 2014;37:48–55. doi: 10.1016/j.jmbbm.2014.05.005 pmid:24942626.
- 13. Manodoro S, Endo M, Uvin P, Albersen M, Vlacil J, Engels A, et al. Graft-related complications and biaxial tensiometry following experimental vaginal implantation of flat mesh of variable dimensions. BJOG: an international journal of obstetrics and gynaecology. 2013;120(2):244–50. doi: 10.1111/1471-0528.12081 pmid:23240803.
- 14. Kruger JA, Nielsen PM, Budgett SC, Taberner AJ. An automated hand-held elastometer for quantifying the passive stiffness of the levator ani muscle in women. Neurourology and urodynamics. 2013. doi: 10.1002/nau.22537 pmid:24285585.
- 15. Mangera A, Bullock AJ, Roman S, Chapple CR, MacNeil S. Comparison of candidate scaffolds for tissue engineering for stress urinary incontinence and pelvic organ prolapse repair. BJU international. 2013;112(5):674–85. Epub 2013/06/19. doi: 10.1111/bju.12186 pmid:23773418.
- 16. Boennelycke M, Christensen L, Nielsen LF, Gras S, Lose G. Fresh muscle fiber fragments on a scaffold in rats-a new concept in urogynecology? American journal of obstetrics and gynecology. 2011;205(3):235 e10-4. Epub 2011/06/21. doi: 10.1016/j.ajog.2011.04.020 pmid:21684520.
- 17. Hung MJ, Wen MC, Hung CN, Ho ES, Chen GD, Yang VC. Tissue-engineered fascia from vaginal fibroblasts for patients needing reconstructive pelvic surgery. International urogynecology journal. 2010;21(9):1085–93. Epub 2010/05/19. doi: 10.1007/s00192-010-1168-3 pmid:20480140.
- 18. Mangera A, Bullock AJ, Chapple CR, Macneil S. Are biomechanical properties predictive of the success of prostheses used in stress urinary incontinence and pelvic organ prolapse? A systematic review. Neurourology and urodynamics. 2012;31(1):13–21. doi: 10.1002/nau.21156 pmid:22038890.
- 19. Aboushwareb T, McKenzie P, Wezel F, Southgate J, Badlani G. Is tissue engineering and biomaterials the future for lower urinary tract dysfunction (LUTD)/pelvic organ prolapse (POP)? Neurourology and urodynamics. 2011;30(5):775–82. doi: 10.1002/nau.21101 pmid:21661029.
- 20. Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart-Akers AM. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue engineering Part A. 2008;14(11):1835–42. doi: 10.1089/ten.tea.2007.0264 pmid:18950271.
- 21. Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity. 2005;23(4):344–6. doi: 10.1016/j.immuni.2005.10.001 pmid:16226499.
- 22. Claerhout F, Verbist G, Verbeken E, Konstantinovic M, De Ridder D, Deprest J. Fate of collagen-based implants used in pelvic floor surgery: a 2-year follow-up study in a rabbit model. American journal of obstetrics and gynecology. 2008;198(1):94 e1-6. doi: 10.1016/j.ajog.2007.05.032 pmid:18166318.
- 23. Roman Regueros S, Albersen M, Manodoro S, Zia S, Osman NI, Bullock AJ, et al. Acute in vivo response to an alternative implant for urogynecology. BioMed research international. 2014;2014:853610. doi: 10.1155/2014/853610 pmid:25136633; PubMed Central PMCID: PMC4124768.
- 24. Lei L, Song Y, Chen R. Biomechanical properties of prolapsed vaginal tissue in pre- and postmenopausal women. International urogynecology journal and pelvic floor dysfunction. 2007;18(6):603–7. doi: 10.1007/s00192-006-0214-7 pmid:17024520.
- 25. Roman S, Mangera A, Osman NI, Bullock AJ, Chapple CR, Macneil S. Developing a tissue engineered repair material for treatment of stress urinary incontinence and pelvic organ prolapse-which cell source? Neurourology and urodynamics. 2013. Epub 2013/07/23. doi: 10.1002/nau.22443 pmid:23868812.
- 26. Bye FJ, Bissoli J, Black L, Bullock AJ, Puwanun S, Moharamzadeh K, et al. Development of bilayer and trilayer nanofibrous/microfibrous scaffolds for regenerative medicine. Biomaterials Science. 2013;1(9):942–51. doi: 10.1039/C3BM60074B.
- 27. Jackson WM, Nesti LJ, Tuan RS. Mesenchymal stem cell therapy for attenuation of scar formation during wound healing. Stem cell research & therapy. 2012;3(3):20. Epub 2012/06/07. doi: 10.1186/scrt111 pmid:22668751; PubMed Central PMCID: PMC3392767.
- 28. Bergmeister H, Seyidova N, Schreiber C, Strobl M, Grasl C, Walter I, et al. Biodegradable, Thermoplastic Polyurethane Grafts For Small Diameter Vascular Replacement. Acta biomaterialia. 2014. doi: 10.1016/j.actbio.2014.09.003 pmid:25218664.
- 29. Takanari K, Hong Y, Hashizume R, Huber A, Amoroso NJ, D'Amore A, et al. Abdominal wall reconstruction by a regionally distinct biocomposite of extracellular matrix digest and a biodegradable elastomer. Journal of tissue engineering and regenerative medicine. 2013. doi: 10.1002/term.1834 pmid:24376045.